EYEPOINT INC (EYPT:NASDAQ)
$13.3 0.26 (1.9939%)
Analysed EYEPOINT INC (EYPT:NASDAQ) News Sources
EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data
14-05-2026
yahoo.com
Assessing EyePoint (EYPT) Valuation After Recent Share Price Weakness
17-05-2026
yahoo.com
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
17-05-2026
fool.com
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
17-05-2026
fool.com
EyePoint Announces Participation at Upcoming Investor Conferences
19-05-2026
yahoo.com
How The EyePoint (EYPT) Narrative Is Evolving With DURAVYU Trials And New Analyst Targets
21-05-2026
yahoo.com
EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears
26-05-2026
marketbeat.com
Here’s Why EyePoint, Inc. (EYPT) Is Among the Best Get Rich Quick Stocks
07-07-2026
yahoo.com
EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer
13-07-2026
yahoo.com
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16-07-2026
yahoo.com
What is the current price of EYEPOINT INC (EYPT:NASDAQ)?
The current price of EYEPOINT INC (EYPT:NASDAQ) is $13.3.
EYEPOINT INC (EYPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of EYEPOINT INC (EYPT:NASDAQ) since the previous trading day is $0.26.
EYEPOINT INC (EYPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of EYEPOINT INC (EYPT:NASDAQ) since the previous trading day is 1.9939%.
What is the most recent average sentiment score for EYEPOINT INC (EYPT:NASDAQ)?
The most recent average sentiment score for EYEPOINT INC (EYPT:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for EYEPOINT INC (EYPT:NASDAQ)?
The most recent sentiment for EYEPOINT INC (EYPT:NASDAQ) is .
SEC-8K** Filing Available For EYEPOINT INC (EYPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.